Since the PI3K/Akt and MDM2-p53 signal pathways are associated with the proliferation, carcinogenesis, and apoptosis of cells, we speculated that BBM may exhibit anticancer effects in lung cancer cells through PI3K/Akt and MDM2-p53 signaling pathways. This evidence concerns the gene AKT1 and lung cancer.